Glycyrrhizin Induces Melanogenesis by Elevating a cAMP Level in B16 Melanoma Cells  by Lee, Jongsung et al.
Glycyrrhizin Induces Melanogenesis by Elevating a cAMP Level in
B16 Melanoma Cells
Jongsung Lee, Eunsun Jung, Junho Park, Kwangseon Jung, Eunkyung Park, Jieun Kim, Sungtaek Hong,
Jinil Park, Sanghee Park, Sangyeop Lee, and Deokhoon Park
Biospectrum Life Science Institute, Kumpo-City, Kyunggi-do, Korea
In mammalian melanocytes, melanin synthesis is controlled by tyrosinase, the critical enzyme in the melanogenic
pathway. A recent report showed that the stimulation of melanogenesis by glycyrrhizin (GR) is because of an
increased tyrosinase expression at mRNA and protein levels. But, the molecular events of melanogenesis induced
by GR remain to be elucidated. In this study, using B16 melanoma cells, we showed that GR activated activator
protein-1 (AP-1) and cyclic response ﬁlament ‘‘CRE’’ promoters, but not the nuclear factor-jB promoter. In addition,
although GR stimulated mitogen-activated protein (MAP) kinase, p42/44mapk, consistent with GR-induced AP-1
promoter activation, GR-induced melanogenesis was not blocked by PD98059, an MEK1 inhibitor, suggesting that
MAPkinase induced by GR does not have a direct effect on the level of melanin content. But, GR-induced melano-
genesis was inhibited by an inhibitor of protein kinase A (H-89). This result was further conﬁrmed by the fact that
GR induced the phosphorylation of CRE binding protein (CREB) and inhibition of glycogen synthase kinase 3b
phosphorylation as well as the production of cAMP, indicating that GR induces melanogenesis through cAMP
signaling. In addition, the fact that GR-induced CRE activation was blocked by H-89 but GR-induced increase of
cAMP production was not suggests that GR operates upstream of protein kinase A.
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Glycyrrhizin (GR) is present in large quantities in the roots and
rhizomes of licorice, Glycyrrhiza glabra L., and is composed
of a molecule of glycyrrhetinic acid and two molecules of
glucuronic acid. GR is an effective anti-inflammatory agent
used in Chinese medicine (Finney and Somers, 1959; Dargan
and Subak-Sharpe, 1985), and several of its biological activ-
ities have been identified in the human body, i.e., hypo-
lipidemic (Ohminami et al, 1984), anti-oxidative (Ohminami
et al, 1984), anti-viral (Pompei et al, 1979), and interferon-g
inducing activities (Abe et al, 1982).
In melanocytes and melanoma cells, melanogenesis is
controlled by a cascade of enzymatic reactions regulated at
the level of tyrosinase. This enzyme synthesizes dopaqui-
none from tyrosine and appears to control the rate-limiting
step of melanogenesis. Melanin synthesis is stimulated by a
large number of effectors, including 1-oleyl-2-acetyl-glyc-
erol (Gordon and Gilchrest, 1989), ultraviolet B radiations
(Friedmann and Gilchrest, 1987), cAMP-elevating agents
(forskolin, IBMX, a-MSH), and GR (Wong and Pawelek,
1975; Halaban et al, 1981; Hunt et al, 1994). Protein kinase
C was thought to be involved in the induction of melano-
genesis by 1-oleyl-2-acetyl-glycerol and ultraviolet B radi-
ations (Friedmann et al, 1990; Agin et al, 1991). A report
(Carsberg et al, 1994) showed, however, that the stimulation
of melanogenesis by these agents was not affected by
RO485, a potent inhibitor of protein kinase C. Although the
role of protein kinase C in the induction of melanogenesis
remains controversial, compelling data have shown that the
cAMP pathway plays a key role in the regulation of melano-
genesis, augmenting the enzyme activity of pre-existing
tyrosinase and increasing tyrosinase mRNA (Wong and
Pawelek, 1975; Halaban et al, 1981; Hunt et al, 1994). cAMP,
through activation of protein kinase A (PKA) and CRE bind-
ing protein (CREB) transcription factor, promotes an in-
crease in the expression of microphthalamia-associated
transcription factor (MITF) (Bertolotto et al, 1998), a me-
lanocyte-specific transcription factor crucial for melanocyte
development and differentiation (Hodgkinson et al, 1993;
Steingrimsson et al, 1994). As a result, MITF binds to and
activates the tyrosinase promoter, leading thereby to stim-
ulation of melanogenesis (Goding and Fisher, 1997; Sato
et al, 1997; Yasumoto et al, 1997). In addition, a recent re-
port has shown that GR is involved in melanogenesis (Jung
et al, 2001). This effect of GR on melanogenesis is because
of the augmentation of both tyrosinase mRNA and TRP-2
mRNA. But, the molecular events connecting the stimula-
tion of tyrosinase activity or the activation of tyrosinase
gene expression to melanogenesis in response to the GR
remain to be identified.
In this report, using the well-characterized mouse me-
lanoma cells B16, we aimed to elucidate the signal trans-
duction pathway of GR-induced melanogenesis.
Abbreviations: AP-1, activator protein-1; CREB, CRE binding
protein; GR, glycyrrhizin; GSK 3b, glycogen synthase kinase 3b;
MEKK-1, MAPK kinase kinase-1; MITF, microphthalamia-associ-
ated transcription factor; NF-kB, nuclear factor-kB; PKA, protein
kinase A
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Results
GR increases both melanin content and expression of
tyrosinase gene in B16 melanoma cells As a first step to
determine the signal transduction pathway of GR-induced
melanogenesis, we confirmed the effects of GR on melanin
content and expression of tyrosinase gene. As previously
reported (Jung et al, 2001), GR increases both melanin
content and expression of tyrosinase gene (Fig 1A and C).
Namely, melanin formation was enhanced in response to a
serial concentration of GR, 0.2, 0.5, 1.0, and 1.5 mM, re-
spectively. Beyond 1 mM of GR, melanin content did not
increase (data not shown), indicating that the optimal ef-
fective concentration of GR is 1 mM. To exclude the pos-
sibility that increases in melanin content may be induced by
the cell-proliferating effect of GR, 3-(4,5-dimetylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay was per-
formed (Fig 1B). And western blot with b-actin was also
used as a quantitative control for analysis of expression
level of tyrosinase gene. According to these results, we hy-
pothesized that GR-induced melanin formation may be me-
diated via the activation of a tyrosinase gene expression.
GR activates activator protein-1 (AP-1) and CRE pro-
moters, but not an nuclear factor-jB (NF-jB) promot-
er As previously mentioned, GR induced tyrosinase gene
expression. Until now, however, the signal transduction
pathway of GR that activates the tyrosinase promoter had
not yet been disclosed. Therefore, to this end, we utilized a
reporter assay system including AP-1, CRE, and NF-kB-
luciferase reporters. In this experiment, we found that GR
activates AP-1 and CRE promoters, not an NF-kB promoter,
suggesting that AP-1 activation signaling and cAMP signa-
ling may be involved in the activation of the tyrosinase pro-
moter directly or indirectly (Fig 2).
GR activates p42/44mapk through Ras, not MAPK kin-
ase kinase-1 (MEKK-1) Figure 2 shows the possibility that
GR has the potential to induce AP-1 activation and this GR’s
AP-1 activation effect may contribute to the activation of the
tyrosinase promoter since the tyrosinase promoter has two
AP-1-like sequence. To further confirm this fact, we de-
signed the experiment to elucidate whether GR can acti-
vates p42/44mapk in B16 melanoma cells because MAPK
activation was known to be involved in melanogenesis (Hi-
roshi et al, 2001). As shown in Fig 3A, we discovered that
GR activated MAPK, in accordance with GR-induced acti-
vation of the AP-1 promoter. As a positive control, 20%
serum treatment was used. In addition, GR-induced MAPK
activation was blocked by PD98059 (MEK1 inhibitor), con-
firming that GR induces MAPK activation.
AP-1 activation is known to be achieved through Ras-Raf
or Ras-MEKK-1. Therefore, to decipher the action step of
GR in GR-induced AP-1 activation pathway, we introduced
the dominant negatives of Ras and MEKK-1 into an AP-1
luciferase reporter system. GR-induced activation of the
AP-1 reporter was diminished by a dominant negative of
Ras, but not a dominant negative of MEKK-1 (Fig 3B). This
result indicates that GR does not induce AP-1 activation
through the Ras-MEKK-1-MAPK pathway and also oper-
ates upstream of Ras, suggesting the possibility that GR-
induced AP-1 activation may be mediated through the Ras-
Raf-MAPK pathway. To check the expressions of DnRas
and DnMEKK-1, western blot using anti-Flag antibodies
was performed.
Figure1
GR increases the melanin content level and tyrosinase protein
level in B16 melanoma cells. (A) Melanin content assay, (B) MTT as-
say, and (C) western blot analysis of tyrosinase protein. B16 cells
treated for 48 h with GR were analyzed by melanin content assay, and
MTT assay, respectively (A, B). Data (A, B) are expressed as percent
change of the melanin content level relative to untreated control
(mean  SEM). po0.01, po0.001. Protein extracts from B16 cells
treated with GR for 48 h were western blotted and probed first with
anti-tyrosinase antibodies, followed by anti-b actin antibodies (C). FK,
forskolin; GR, glycyrrhizin, MTT, 3-(4,5-dimetylthiazol-2-yl)-2,5-dip-
henyltetrazolium bromide.
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GR-induced melanogenesis through cAMP signaling,
not through MAPK activation As previously mentioned,
we found that GR activated MAPK. Therefore, to test the
possibility that MAPK activation has a direct effect on GR-
induced melanogenesis, we performed a melanin content
assay in B16 melanoma cells, using the MEK1 inhibitor,
PD98059. Unlike many reports that indicate that AP-1 ac-
tivation induces melanogenesis (Walter et al, 1998; Hiroshi
et al, 2001), blocking of GR-induced MAPK activation with
MEK1 inhibitor did not reduce the level of melanin content
(Fig 4), suggesting that GR-induced melanogenesis is
mediated by another signal, not by the MAPK activation
pathway.
Although tyrosinase promoter does not contain the CRE
promoter, GR activated the CRE promoter (Fig 2). Therefore,
we checked the possibility of the involvement of cAMP
signaling in GR-induced melanogenesis. As a first step, we
tested whether or not GR induces cAMP production in B16
melanoma cells. As shown in Fig 5A, we found that cAMP
production increased upon treatment with GR. In addition,
according to a CRE Luc reporter assay using H-89 (PKA
inhibitor), H-89 was shown to inhibit GR-induced CRE pro-
moter activation, further supporting the fact that GR induc-
es cAMP signaling. These results also suggest that GR
operates upstream of protein kinase A and is a membrane-
proximal event (Fig 5B).
GR induces CREB phosphorylation and reduction of
glycogen synthase kinase 3b (GSK 3b) phosphorylat-
ion Until now, we found that GR induces cAMP production
and operates upstream of PKA. To further demonstrate the
involvement of cAMP signaling of GR-induced melanogen-
esis, western analysis was designed to detect the phos-
phorylation level of CREB and GSK 3b, which are known to
be involved in tyrosinase gene expression through upreg-
ulation of MITF gene expression. As shown in Fig 6A, GR
increased the level of phosphorylation of CREB in a time-
Figure 2
Glycyrrhizin (GR) activates activator protein (AP-1), and CRE pro-
moters, but not the nuclear factor-jB (NF-jB) promoter. B16 me-
lanoma cells were transfected with AP-1-Luc, CRE-Luc, or NF-kB-Luc
reporters along with Renilla luciferase expression vector driven by thy-
midine kinase promoter (Promega) using superfect reagent (Invitrogen).
After incubation for 24 h, cells were stimulated for 14 h by GR (1 mM),
PDGF (10 ng per mL), forskolin (20 mM), or TNF-a (10 ng per mL) and
then harvested, and assayed. Renilla luciferase vector was used as a
control for transfection efficiency and the reporter data were processed
using the dual luciferase method as described in Materials and Meth-
ods. Results were confirmed by three independent transfections. Data
are expressed as percent change of the luciferase activity relative to
untreated control (mean  SEM). po0.01, po0.001. FK, forskolin.
Figure3
Glycyrrhizin (GR) activates p42/44 mapk through Ras, not MAPK
kinase kinase-1 (MEKK-1). (A) MAPK activation induced by GR (1
mM), (B) hierarchy of GR that operates in activator protein-1 (AP-1)
activation. (A) B16 melanoma cells were pre-treated with 10 mM
PD98059 for 1 h and then treated with GR (1 mM) or 20% serum for 2 h.
After some time, B16 melanoma cells were harvested and were then
subjected to western blot analysis using anti-phospho-MAPK Ab or
anti-MAPK Ab. (B) B16 melanoma cells were transfected with AP-1-Luc
reporters along with a Renilla luciferase expression vector driven by a
thymidine kinase promoter (Promega) using Superfect reagent (Invitro-
gen). After incubation for 24 h, cells pre-treated with or without 10 mM
PD98059 for 1 h were stimulated for 14 h by GR, and then harvested
and assayed. Results were confirmed by three independent transfect-
ions. Data are expressed as means  SEM. po0.05, po0.001,
compared with untreated control; opo0.05, oopo0.001 versus GR (1
mM) only. Flag-tagged DnRas and Flag-tagged DnMEKK-1 were de-
tected with anti-Flag antibodies. DnRas, a dominant negative form of
Ras, DnMEKK-1, a dominant negative form of MEKK-1.
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dependent manner, indicating the involvement of GR in
cAMP signaling. This fact was more strengthened by the
result that the level of GSK 3b phosphorylation was inhibited
by GR treatment. According to these results, we concluded
that GR induces cAMP signaling pathway in B16 melanoma
cells and the possibility that cAMP signaling plays a critical
role in GR-induced melanogenesis was suggested. As a
positive control in both western blots, forskolin was intro-
duced, and CREB and b-actin were used as a quantitative
control in Fig 6A and B, respectively.
GR regulates tyrosinase gene expression and melanin
content level through cAMP signaling To directly dem-
onstrate the involvement of cAMP signaling in GR-induced
melanogenesis, a melanin content assay and western blot
for tyrosinase were performed using H-89, a cAMP-de-
pendent protein kinase A inhibitor. As shown in Fig 7A, the
GR-induced upregulation of tyrosinase gene expression
was reduced by H-89. In addition, consistent with this,
melanin formation induced by GR was conspicuously re-
duced by H-89 (Fig 7B), indicating the involvement of cAMP
signaling in GR-induced melanogenesis.
Collectively, our data indicate that GR-induced increase
of intracellular cAMP level is connected with CREB phos-
phorylation and tyrosinase gene activation. To further con-
firm this, the effect of GR on MITF expression was studied.
As shown in Fig 7C, consistent with our hypothesis, MITF
gene expression was induced by GR. As a positive control
for western blotting, forskolin was introduced.
Discussion
The molecular mechanism by which GR stimulates melanin
synthesis in melanoma cells remains to be identified. To
achieve this aim, we have characterized the signal trans-
duction pathway of GR-induced melanogenesis. Several
features demonstrate that GR induces melanogenesis
through cAMP signaling pathway: (1) Although GR acti-
vates an MAPK, PD98059 (MEK1 inhibitor) does not inhibit
GR-induced melanogenesis. (2) GR-induced CRE activation
and cAMP production. (3) Although phosphorylation of
CREB is induced by GR, the phosphorylation level of GSK
3b is reduced upon treatment with GR. (4) GR-induced in-
crease of tyrosinase gene expression and melanin content
level is inhibited by H-89. The fact that dominant-negative
Ras, when ectopically expressed, blocked GR-induced AP-
1 activation or H-89, PKA inhibitor, blocked GR-induced
CRE activation, indicates that the GR’s action step in
Figure 4
Glycyrrhizin (GR)-induced increase of melanin content was not re-
duced by PD98059, MEK1 inhibitor. B16 cells, pre-treated with 10 mM
PD98059 for 1 h, were treated for 48 h with GR and then analyzed by
melanin content assay. Data are expressed as the percent change of
the melanin content level relative to untreated control (mean  SEM).
Data were expressed as indicated in Materials and Methods. po0.01,
po0.001 compared with untreated control. opo0.05, oopo0.001
versus GR (1 mM) only. AP-1, activator protein-1, NF-kB; nuclear fac-
tor-kB.
Figure5
Glycyrrhizin (GR) induces cAMP production (A) and operates up-
stream of protein kinase A (B) in B16 melanoma cells. B16 me-
lanoma cells were treated with GR (1 mM) or forskolin (10 mM) or GR
plus H-89 for 14 h. After some time, cAMP level was detected using a
cAMP kit from R&D systems. Data are expressed as means  SEM.
po0.05, po0.001, compared with untreated control (A). B16 me-
lanoma cells were transfected with CRE-Luc reporters along with a
Renilla luciferase expression vector driven by a thymidine kinase pro-
moter (Promega) using Superfect reagent (Invitrogen). After incubation
for 24 h, cells pre-treated with or without 10 mM H-89 for 1 h were
stimulated for 14 h by GR, and then harvested, lysed, and assayed.
Results were confirmed by three independent transfections. Data are
expressed as means  SEM. po0.05, po0.001, compared with
untreated control. opo0.05, oopo0.001 versus GR (1 mM) only (B). FK,
forskolin.
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melanogenesis is membrane-proximal. This fact is further
strengthened by the result that GR-induced melanogenesis
was blocked by H-89.
In our promoter assay, we found that GR activated AP-1
and CRE promoters, not the NF-kB promoter. Therefore, we
considered the involvement of AP-1 and CRE elements in
GR-induced melanogenesis. The mouse tyrosinase pro-
moter has two AP-1-like sequences (2.1 and 0.18 kb up-
stream transcription start site), suggesting that AP-1
activation by GR could lead to increased tyrosinase gene
expression. In addition, Hiroshi et al reported that UVA-in-
duced melanogenesis is mediated through extracellular
signal-related kinase (ERK) 1/2 activation. To test the pos-
sible involvement of AP-1 activation in GR-induced melano-
genesis, a melanin content assay was performed using
PD98059. As presented in Fig 4, the GR-induced increase in
melanin content was not blocked, suggesting that the AP-1
activation pathway has no direct effect on GR-melanogen-
esis. But, we cannot exclude the possibility that AP-1 ac-
tivation pathway may have a regulatory role in GR-induced
melanogenesis. Therefore, in the light of this result, our
finding partially supports the report that inhibition of ERK
pathway induces melanin synthesis (Walter et al, 1998).
cAMP-induced melanogenesis has been reported to be
mediated by a CRE promoter through the binding of CREB
family transcription factors that are phosphorylated and
activated by protein kinase A (Karin, 1994). No canonical
Figure 6
Glycyrrhizin (GR) induces phosphorylation of CRE binding protein
(CREB) (A) but reduces phosphorylation of glycogen synthase kin-
ase 3b (GSK 3b) (B). B16 cells were left untreated or were incubated
with 1 mM GR or 10 mM forskolin for 5 or 15 min (A) or with 70 ng per
mL C. sordelii LT, 10 mM forskolin (FK), or 1 mM GR for 2 h. Western
blots were next performed with phospho-specific antibodies such as
phospho-CREB or phospho-GSK 3b antibody. Detection of CREB
and b-actin showed that each lane was loaded with equal amounts of
protein.
Figure7
Effect of H-89 on glycyrrhizin (GR)-induced increase of tyrosinase
expression (A), melanin content level (B) and microphthalamia-as-
sociated transcription factor (MITF) expression. B16 cells pre-treat-
ed with or without 10 mM H-89 for 1 h were stimulated with GR (1 mM)
or forskolin (FK) (10 mM) for 48 h, and then subjected to western blot
analysis using anti-tyrosinase Ab, anti-b actin Ab (A), and anti-MITF Ab,
anti-b actin Ab (C), or melanin content assay (B). Data are expressed as
the percent change of the melanin content level relative to untreated
control (mean  SEM). po0.01, po0.001 compared with untreated
control. opo0.05, oopo0.001 versus GR (1 mM) only.
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CRE was, however, found in the mouse tyrosinase promot-
er. Thus, we hypothesized that GR might induce melano-
genesis through the indirect activation of the tyrosinase
promoter because MITF, which was known to be involved in
melanogenesis by cAMP-elevating agents, has a CRE ele-
ment in its promoter. As expected, H-89, a PKA inhibitor,
reduced the melanin content formed by GR, indicating the
involvement of the CRE activation pathway in GR-induced
melanogenesis. This result was additionally confirmed by
the fact that GR induced the phosphorylation and activation
of CREB in B16 melanoma cells.
GSK 3b has been widely implicated in cell homeostasis
by its ability to phosphorylate a broad range of substrates
including the glycogen synthase, the microtubule-associ-
ated protein t, and b-catenin (Frame and Cohen, 2001).
Recently, a report (Takeda et al, 2000) showed that
unphosphorylated GSK 3b restores its activity, and phos-
phorylates MITF on serine 289, thereby enhancing its bind-
ing to the tyrosinase promoter. In the light of this report, we
examined the possibility that GSK 3b phosphorylation may
be inhibited by GR. In our study, we found that GSK 3b
phosphorylation was reduced by GR.
Together, the data gathered in this study demonstrate
that GR induces melanogenesis by elevating intracellular
cAMP level. In addition, the fact that GR-induced AP-1 re-
porter activation was blocked by DnRas, a dominant-neg-
ative form of Ras and GR-induced CRE reporter activation
was blocked by H-89, a PKA inhibitor, suggests that GR
operates upstream of Ras and PKA, which are known to be
downstream molecules of cAMP. That is, this means that
GR is able to activate both AP-1 and CRE pathways by
increasing intracellular cAMP level.
Materials and Methods
Materials Minimum essential medium (MEM) and polyclonal rabbit
antisera to human tyrosinase were from Santa Cruz Biotechnology
(Santa Cruz, California). Antisera to phospho-p42mapk and p44mapk
and PD98059 (20-amino-30-methoxyflavone) were purchased from
Cell Signaling Technology (Beverly, Massachusetts). Antibodies
against b-actin and flag, GR, EGF, forskolin, clostriajum sordelii
betbal toxin ‘‘C. sordelii LT,’’ and TNF-a are from Sigma Chemical,
St. Louis, Missouri. The protease inhibitor cocktail was purchased
from Roche (Indianapolis, Indiana). The chemiluminescence kit
was purchased from Amersham Pharmacia Biotech (Buckingham-
shire, UK). AP-1 Luc, CRE-Luc, and NF-kB-Luc reperter plasmids
were purchased from Stratagene, La Jolla, California. Flag-tagged
DnRas and Flag-tagged DnMEKK-1 are gifts from Dr Won (Mogam
Biotech Res Inst, Yongin, Korea).
Cell cultures B16/BL6 murine melanoma cells were cultured in
MEM with 10% fetal bovine serum and penicillin/streptomycin (100
IU/50 g per mL) in a humidified atmosphere containing 5% CO2 in
air at 371C.
MTT assay The general viability of cultured cells was determined
by reduction of MTT to formazan. After GR treatment, cells were
incubated for 24 h at 371C in 5% CO2 atmosphere. MTT (1 mg per
mL in phosphate-buffered saline (PBS)) was added to each well,
one of ten volume of media. Cells were incubated at 371C for 3 h,
and dimethyl sulfoxide was added to dissolve the formazan crys-
tals. The absorbance was then measured at 570 nm with a spec-
trophotometer.
Melanin content assay Melanin contents of cultured B16/BL6
cells were measured according to the method of Oka et al (1996)
with a slight modification. The colors of cell pellets were evaluated
visually, and pellets were solubilized in boiling 1 M NaOH for 10
min. Spectrophotometric analysis of melanin content was per-
formed at 400 nm absorbance.
Western blot analysis B16 cell lysates were separated by SDS-
PAGE (16% acrylamide gels) and transferred to Hybond-C mem-
branes. The blots were probed with tyrosinase, MITF, b-actin, flag,
CREB, phospho-CREB, p42/44 MAPK, and phospho-GSK 3b an-
tibodies and then proteins were visualized by the Amersham ECL
system (Piscataway, New Jersey).
Measurement of MAP kinase activity Phosphorylated MAP kin-
ase isoform, p42 MAP kinase (ERK-2) and p44 MAP kinase (ERK-
1), were identified by western blotting analysis using anti-phospho
MAP kinase antibody. In brief, cultured melanoma cells were
washed with ice-cold PBS (pH 7.4), and then 0.2 mL of lysis buffer
(10 mM Tris-HCl (pH 7.4) containing 150 mM NaCl, 2 mM EGTA, 2
mM dithiothreitol, 1 mM sodium orthovanadate, 1 mM phenyl-
methylsulfonyl fluoride, 10 mg per mL leupeptin, 10 mg per mL
aprotinin) were added, followed by the harvesting of B16 me-
lanoma cells. After centrifugation at 16,000  g for 30 min at 41C,
the cell lysates were denatured in boiling water for 5 min. Samples
of the supernatant were subjected to SDS-PAGE using a 16% po-
lyacrylamide gel. After electrophoresis, proteins were transferred to
Hybond-C membrane at 4oC. For the detection of phosphorylated
p42 MAP kinase and p44 MAP kinase, the sheets were immersed
in blocking buffer containing 5% skim milk, 20 mM Tris-buffered
saline (pH 7.4), 0.1 % Tween-20 for 3 h at 251C. Phosphorylation of
p42 and p44 MAP kinases was detected by protein immunoblot-
ting using a 1:1000 dilution of rabbit polyclonal dual phospho-
specific antibodies. Blots were developed by enhanced chemilu-
minesence following incubation with HRP-conjugated secondary
anti-rabbit IgG monoclonal antibody (1:2000 dilution) for 1 h at
251C according to the manufacturer’s instructions.
Luciferase reporter assay To assay for the NF-kB, AP-1, and
CRE promoter activities, B16 melanoma cells were transfected
with AP-1-Luc, CRE-Luc, or NF-kB-Luc reporters along with Ren-
illa luciferase expression vector driven by thymidine kinase pro-
moter (Promega, Madison, Wisconsin) using superfect reagent
(Invitrogen, Carlsbad, California). After incubation for 24 h, cells
were stimulated for 14 h by GR, and then harvested and lysed.
Supernatants were assayed for luciferase activity. Luciferase ac-
tivity was determined using a Dual Luciferase Assay system
(Promega) and an LB953 luminometer (Berthold, Wildbed, Germa-
ny) and was expressed as a ratio of the AP-1, CRE, or NF-kB-
dependent firefly luciferase activity divided by the control thymi-
dine kinase Renilla luciferase activity (% control). Results were
confirmed by three independent transfections.
cAMP immunoassay cAMP concentration was analyzed using a
cAMP kit from R&D systems (Minneapolis, Minnesota). In brief,
B16 cells (7  104) were lysed in 0.1 M of HCL to inhibit phosp-
hodiesterase activity. Supernatants were collected, neutralized,
and diluted. Following neutralization and dilution, a fixed amount of
cAMP conjugate (alkaline phosphata-labeled cAMP) was added
to compete with cAMP in the cell lysates for sites on a rabbit
polyclonal antibody immobilized on a 96-well plate. After a wash
to remove excess conjugated and unbound cell lysate cAMP, a
substrate solution was added to the wells to determine the bound
enzyme activity. The color development was stopped and the
absorbance was read at 405 nm. The intensity of the color was
inversely proportional to the concentration of cAMP in the
cell lysates. All studies were repeated at least three times.
Data are expressed as means  SEM, po0.05, po0.001, com-
pared with untreated control. opo0.05, oopo0.001 versus GR
(1 mM) only.
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Statistical evaluation Averages  SEM of the means were cal-
culated; statistical analysis of results was performed by Student’s t
test for independent samples. Values of po0.05 and po0.001
were considered significant.
DOI: 10.1111/j.0022-202X.2004.23606.x
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